GS1191-0445 Injection

· Gritgen Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GS1191-0445 Injection, covering 2025-12-09 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Safety and Efficacy of GS1191-0445 Injection in the Treatment of Severe Hemophilia A [Phase 1, Phase 2]

See pricing